Alice Zhang is the CEO and Co-founder of Verge Genomics. Verge Genomics uses artificial intelligence to develop better drugs, faster for diseases like ALS, Parkinson’s Disease, and Alzheimer’s Disease. Alice has been recognized for her work as a Forbes 30 Under 30 Featured Honoree, MIT Technology Review’s Innovator Under 35, and SF Business Times’ 40 Under 40. She currently sits on the board of directors at the California Life Sciences Association. Prior to Verge, she spent five years in the UCLA-Caltech MD/PhD program and received her BA degree from Princeton University in Molecular Biology. In her spare time, Alice also is an angel investor and advisor for tech-enabled bio startups.